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Abstract
Background: Reduction in brain volume, especially gray matter volume, has been shown to be one of the many deleterious 
effects of prolonged alcohol consumption. High variance in the degree of gray matter tissue shrinkage among alcohol-
dependent individuals and a previous neuroimaging genetics report suggest the involvement of environmental and/or 
genetic factors, such as superoxide dismutase 2 (SOD2). Identification of such underlying factors will help in the clinical 
management of alcohol dependence.
Methods: We analyzed quantitative magnetic resonance imaging and genotype data from 103 alcohol users, including both 
light drinkers and treatment-seeking alcohol-dependent individuals. Genotyping was performed using a custom gene array 
that included genes selected from 8 pathways relevant to chronic alcohol-related brain volume loss.
Results: We replicated a significant association of a functional SOD2 single nucleotide polymorphism with normalized 
gray matter volume, which had been reported previously in an independent smaller sample of alcohol-dependent 
individuals. The SOD2-related genetic protection was observed only at the cohort’s lower drinking range. Additional 
associations between normalized gray matter volume and other candidate genes such as alcohol dehydrogenase gene 
cluster (ADH), GCLC, NOS3, and SYT1 were observed across the entire sample but did not survive corrections for multiple 
comparisons.
Conclusion: Converging independent evidence for a SOD2 gene association with gray matter volume shrinkage in chronic 
alcohol users suggests that SOD2 genetic variants predict differential brain volume loss mediated by free radicals. This study 
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also provides the first catalog of genetic variations relevant to gray matter loss in chronic alcohol users. The identified gene-
brain structure relationships are functionally pertinent and merit replication.
Keywords: Alcohol use disorder, gray matter volume, superoxide dismutase 2 (SOD2), neuroimaging, genetics
Introduction
Alcohol use disorders are associated with neurodegenerative 
processes (de la Monte and Kril, 2014), and brain imaging has 
been used to demonstrate the adverse effects of chronic alco-
hol consumption on brain structure and morphometry (Buhler 
and Mann, 2011). One of the most consistent findings is a reduc-
tion of gray matter (GM) and white matter (WM) volumes, which 
results in whole brain volume shrinkage in individuals with 
alcohol use disorders compared with age-matched light- or 
non-drinking controls. Such atrophy, measured by quantita-
tive in vivo magnetic resonance imaging (MRI), has been related 
to wide-ranging deficits in cognitive and motor functions (e.g., 
Sullivan et al., 2010). The exact mechanisms by which chronic 
alcohol consumption produces these brain effects are under 
intense investigation, and several molecular pathways have 
been implicated via in vitro and in vivo model systems and 
through the study of postmortem human brains (for review, see 
e.g., Mukherjee, 2013).
One such injury mechanism is oxidative stress from free 
radicals such as reactive oxygen species (ROS) and reactive 
nitrogen species (RNS), induced by alcohol and its metabolic 
byproducts. The excessive alcohol-associated production of free 
radical species shifts the delicate balance required for normal 
cellular function between the amount of free radicals (such 
as superoxide anion and peroxynitrite) and antioxidant mol-
ecules/enzymes (such as glutathione, catalase, and superoxide 
dismutase [SOD]) that exist in the body to reduce these active 
radicals and counterbalance their damaging effects on cellular 
tissue. The excess in free radicals and a potentially associated 
failure of antioxidant mechanisms to quickly and efficiently 
remove ROS/RNS cause oxidative/nitrosative cellular stress. This 
leads to increased oxidation of DNA, proteins, and lipids; disrup-
tion of cellular and mitochondrial membranes; and eventually 
to damaged neurons and apoptotic or necrotic cell death (Kumar 
et al., 2013; Reddy et al., 2013). On a macromolecular scale, such 
damage is reflected qualitatively in atrophy and quantitatively 
in brain tissue volume reductions seen on brain MRI of individu-
als with alcohol use disorders.
The brain is particularly susceptible to oxidative stress due 
to its relatively high content of polyunsaturated fatty acids, 
low concentration of antioxidant enzymes, and high level of 
oxygen metabolism (Sun and Sun, 2001). Cellular ROS and RNS 
production from alcohol metabolism and chronic smoking lead 
to diminished neuronal viability (Haorah et al., 2008, Crews and 
Nixon, 2009; Hack et  al., 2009; Durazzo et  al., 2010; Alfonso-
Loeches and Guerri, 2011). An in vivo rat study showed increased 
mitochondrial lipid peroxidation and protein oxidation with 
decreased neurocortical expression of SOD2, a mitochondrial 
enzyme of the SOD family (Reddy et al., 2013). Peripheral SOD2 
activity was also found downregulated in individuals with alco-
hol dependence (Huang et al., 2009a, 2009b). These results and 
others strengthen the link between insufficient antioxidant 
activity and chronic alcohol-associated neurodegeneration and 
atrophy.
Alterations in brain structure potentially related to neu-
rodegenerative processes have been observed by in vivo neu-
roimaging in the majority of studies of treatment-naïve and 
treatment-seeking alcohol-dependent individuals. A  common 
finding is shrinkage of the cortical GM, detected with large 
inter-individual variation both in the severity of effects and the 
magnitude of recovery of neurobiological abnormalities with 
abstinence from alcohol (Cui et al., 2015). This inter-individual 
heterogeneity points to variation in vulnerability of the brain 
to the detrimental effects of chronic alcohol consumption or in 
the brain’s ability to recover; such an inter-individual variation 
may be attributed to an interplay of genetic and environmental 
factors.
Previously, we identified in 76 treatment-seeking alcohol-
dependent individuals an association between greater GM 
shrinkage and a SOD2 homozygous diplotype (rs10370TT-
rs4880GG), containing a functional missense variant (Ala16Val, 
rs4880) (Srivastava et  al., 2010). In this report, we set out to 
replicate the results of a brain structural intermediate phe-
notype in a larger dataset of 103 alcohol-drinking individuals 
and to identify additional potential genetic variants influenc-
ing chronic alcohol-induced morphological brain alteration in 
select genes associated with oxidation and neuronal function. 
To achieve our goals, we used a custom genotyping array 
(Hodgkinson et al., 2008), an approach that is more cost effective 
than whole genome sequencing and more relevant and focused 
than genome-wide association study platforms, yet more pow-
erful and efficient than genotyping individual candidate single 
nucleotide polymorphisms (SNPs). This approach enabled the 
first comprehensive cataloging of relevant genetic variations 
of chronic alcohol-induced brain shrinkage, with the inclusion 
of Ancestry Informative Markers (AIMs) as a method to correct 
for confounding effects of population admixture. The custom 
array included SNPs from 92 loci/genes belonging to/represent-
ing 8 different pathways relevant to chronic alcohol-induced 
neuropathology.
Materials and Methods
Participants
All alcohol-dependent participants were recruited from the VA 
Medical Center Substance Abuse Day Hospital and the Kaiser 
Permanente Chemical Dependence Recovery Program outpa-
tient clinics in San Francisco; non-alcohol-dependent light-
drinking controls were recruited from the Bay Area community. 
Participants provided written informed consent before engag-
ing in study procedures, which conformed to the Declaration of 
Helsinki and were approved by the University of California San 
Francisco and the VA Medical Center. The alcohol-dependent 
individuals were studied by 1.5-Tesla brain imaging at an aver-
age of 32 ± 11  days of abstinence from alcohol and other sub-
stances except tobacco. Primary inclusion criteria were current 
DSM-IV diagnosis of alcohol dependence, fluency in English, 
consumption of >150 alcohol-containing drinks/month (1 alco-
holic drink equivalent = 13.6 g pure alcohol) for at least 8 years 
before enrollment for men and consumption of >80 drinks/mo 
for at least 6 years before enrollment for women. All participants 
completed the Structured Clinical Interview for DSM-IV-Axis 
I Disorders, Patient Edition, Version 2.0, and standardized ques-
tionnaires that assessed average number of alcoholic drinks/
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month consumed over lifetime and lifetime alcohol consump-
tion (LAC) via a lifetime drinking history interview as well as the 
level of nicotine dependence via the Fagerstrom Tolerance Test 
for Nicotine Dependence, including the total number of ciga-
rettes smoked per day and lifetime years of smoking. Primary 
exclusion criteria for all participants are fully detailed elsewhere 
(Durazzo et al., 2004). In brief, all participants were free of psy-
chiatric, neurological, physical, and medical conditions known 
or suspected to influence brain morphology, with the exceptions 
of hepatitis C, hypertension, and Type-2 diabetes; these medi-
cal conditions are highly prevalent in those with alcohol use 
disorders (Mertens et al., 2005; Moss et al., 2010), and excluding 
patients with these conditions would have resulted in a biased 
sample. For alcohol-dependent individuals, current or past 
unipolar mood disorders (e.g., major depression, substance-
induced mood disorder) were not exclusionary given the high 
comorbidity with substance dependence (Mertens et  al., 2003; 
Durazzo et al., 2010). The alcohol-dependent participants were 
monitored for abstinence while in treatment, and they were 
screened for recent alcohol and illicit substances at the time of 
brain imaging to assure abstinence. All study participants pro-
vided a blood sample for extracting genomic DNA at the clinical 
laboratories of the VA.
From a total of 103 individuals enrolled, 93 participants were 
selected for the study proper. Ten individuals were excluded from 
the final analysis due to non-European or African American ances-
try. A total of 71 were European (76%) and 22 were African American 
(24%) as determined by self-report and confirmed by AIMs. The 
median LAC across the entire study sample was 839 kg, and for fur-
ther analysis participants were divided into “low” and “high” drink-
ing groups who had consumed alcohol below and above this median 
split, respectively. The average age of the low drinkers was 48.5 ± 10.8 
and 54.3 ± 6.6 for the high drinkers. The average Fagerstrom total 
score was 4.8 ± 2.0 for the 21 smokers among the low drinkers and 
5.7 ± 1.7 for the 33 smokers among the high drinkers, indicating a 
moderate degree of dependence on tobacco products, predomi-
nantly cigarettes. Both age and Fagerstrom total score were signifi-
cantly different between groups (P < .003) (Table 1). Of the final study 
group, 15 were light-drinking controls (including 3 cigarette smok-
ers) and 70 were recovering alcohol-dependent individuals at about 
1 month of abstinence (including 46 smokers) and 8 were 1-month-
abstinent alcohol-dependent individuals who also were dependent 
on at least one stimulant, primarily cocaine (including 5 smokers).
MRI Data Acquisition and Processing
Brain MRI was performed on a 1.5-Tesla system (Vision, Siemens 
Medical Systems, Iselin, NJ) at the San Francisco VA Medical 
Center as part of a larger study to investigate the effects of absti-
nence from abused substances on brain morphometry and neu-
rocognition. We applied a T1-weighted magnetization prepared 
rapid acquisition gradient echo sequence (TR/TI/TE = 9/300/4 ms, 
1 x 1 mm2 in-plane resolution, 1.5-mm slabs) oriented orthogo-
nal to the long axis of the hippocampus and an oblique-axial 
T2-weighted spin-echo sequence (TR/TE = 2500/80 ms, 1 x 1 mm2 
in-plane resolution, 3-mm slice thickness) oriented along an 
imaginary line connecting the anterior and posterior commis-
sures as seen on a mid-sagittal scout image.
Tissue intensity-based segmentation of cortical and subcortical 
GM, WM, and cerebrospinal fluid (CSF) from T1-weighted images 
was carried out with the semi-utomated expectation-maximiza-
tion segmentation method (Van Leemput et al., 1999). This method 
assigns a probability of GM, WM, and CSF to each MRI voxel based 
on T1-weighted tissue intensity (see Mon et al., 2013 for details). 
The T2-weighted images were used to remove nonbrain tissue 
voxels from the coregistered segmented images. Absolute volumes 
for total cortical GM and WM as well as CSF are reported in mL. 
Intracranial volume (ICV) was calculated as the sum of total tissue 
and CSF volumes. To account for individual variability in ICV, abso-
lute GM and WM tissue volumes for each participant were stand-
ardized to the participant’s ICV, resulting in GM ratio (GMR).
Genetic Analyses
The genetic analyses were performed at the Laboratory of 
Neurogenetics of the National Institute on Alcohol Abuse and 
Alcoholism. The custom array we used included a total of 768 
SNPs from 84 candidate genes (including SOD2) and 8 nonan-
notated loci based on the platform of Illumina Golden gate array 
(Illumina) (supplementary Table 1). A sequence of 5 kb up- and 
1 kb downstream of the candidate gene was searched (NCBI SNP 
build 37.1), and tagging SNPs were identified based on the criteria 
below (details in Hodgkinson et al., 2008). Haplotype tagging SNPs 
for African and European populations that captured haplotypes 
with a frequency of at least 0.006 were selected using a double 
classification tree search algorithm. Based on the haplotype 
block structure, large genes with complex haplotype structures 
were split into 2 or 3 regions and each region was tagged sepa-
rately. Nonsynonymous SNPs, SNPs within 10 bp of intron/exon 
splice sites, were specifically included by forcing these SNPs into 
the panels used for haplotype tagging. Of these 768 SNPs, 142 
SNPs were specifically included as AIMs. These SNPs are a sub-
set of AIMs panel originally described in Enoch et al. (2006). The 
minimum distance between AIM SNPs was 80 kb, and pairwise 
reference allele frequency (RFA) was at least 0.75 (Haploview ver-
sion 4.2), with a 10-fold difference between RFA1 and RFA2. AIMs 
Table 1. Characteristics of Full Study Sample and of Subgroups with LAC below and above Median Split of 839 kg (mean ± SD)
Full Study Sample Low Drinkers (LAC ≤ 839kg) High Drinkers (LAC > 839 kg)
n (females) 93 (7) 46 (6) 47 (1)
Age (y)a 51.4 ± 9.3 48.5 ± 10.8 54.3 ± 6.6
(LAC) (kg) 1032 ± 927 376 ± 247 1711 ± 874
Fagerstrom score (FTND)b 5.3 ± 1.9
(n = 54)
4.8 ± 2.0
(n = 21)
5.7 ± 1.7
(n = 33)
Total GMV (mL) 574.7 ± 52.9 582.1 ± 49.7 567.0 ± 54.9
GMR = GMV/intracranial volume)c 0.379 ± 0.016 0.386 ± 0.016 0.372 ± 0.013
Total WM volume (mL) 402.0 ± 43.9 406.8 ± 49.7 397.2 ± 45.1
WM ratio (= WM volume/intracranial volume)b 0.265 ± 0.015 0.260 ± 0.015 0.269 ± 0.014
Abbreviations: FTND, Fagerstrom Test for nicotine dependence; GM, gray matter; GMR, gray matter ratio; GMV, gray matter volume; LAC, lifetime alcohol consumption; 
WM, white matter.
Low vs high t test: aP = .003, bP = .002, cP < .001.
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data were analyzed using Structure 2.1 to generate population 
assignments for all individuals (Pritchard et al., 2000).
Genotyping was performed according to Illumina GoldenGate 
genotyping protocols for Sentrix BeadChip Array Universal-32 
BeadChip (768 Bead Types V8a). A  total of 500 ng of genomic 
DNA was used per assay. All pre-PCR processing was performed 
using a TECAN liquid handling robot running Illumina protocols. 
Arrays were imaged using an Illumina Beadstation GX500 and 
the data analyzed using GenCall v5.2.0 and GTS Reports soft-
ware v (Illumina). Genotype clusters were manually adjusted to 
correct for the variation arising from DNA integrity. A score of 
zero was assigned for those loci, for which 3 distinct clusters 
could not be resolved. SNPs with a Gencall score <0.25, genotyp-
ing rate <90%, and minor allele frequency <0.05 were excluded. 
Genotyping accuracy for this array in our laboratory was deter-
mined empirically and independent of this particular sample by 
duplicate genotyping of 10% of samples selected randomly, and 
the error rate was determined at <0.05%.
For validation purposes, the SOD2 functional SNP rs4880 in all 
study participants was additionally regenotyped by TaqMan assay 
(C___8709053_10, Applied Biosystems, Foster City, CA) according 
to the manufacturer’s protocol, and the genotype end point was 
determined using the ABI 7900HT Sequence Detection System. 
Genotyping accuracy was determined empirically by duplicate 
genotyping of 25% of the samples selected randomly. The error 
rate was <0.005 and the completion rate was >0.95. No genotyping 
discrepancies between the 2 platforms were identified.
Linkage disequilibrium was calculated for each gene using 
haploview version 4.2. Only 1 SNP was included in regression 
analyses from a pair showing a high correlation (pairwise r2 value 
>0.8). All markers were tested for Hardy-Weinberg Equilibrium.
Statistical Analyses
Statistical tests were performed using the JMP10 (SAS Institute, 
Cary, NC). Normality of distribution of brain volume measures 
was assessed by Shapiro–Wilk W-test and Welch ANOVA testing 
was used for group comparison. If either of the assumption of 
ANOVA was violated, a less powerful, nonparametric Wilcoxon 
rank sums test (Kruskal–Wallis H-test) was used. Mean values 
were calculated for normally distributed variables. An individ-
ual’s GMR was calculated by dividing an individual’s total GM 
volume in mL by his/her ICV in mL. Univariate analyses (ANOVA 
or chi square) determined the independent effects of age, LAC, 
ethnicity, smoking status, or gender on GMR.
The standard least square method was used to construct 
linear regression models with GMR as the dependent variable 
and the following initial independent predictors: gene-specific 
independent SNPs/diplotype, LAC, age, gender, FTND, duration of 
abstinence, and African and European ancestry scores. If a varia-
ble did not significantly contribute to the model (i.e., significance 
level was P > .1), the variable was eliminated from the model in 
an iterative process. Tukey’s HSD analysis was used as a posterior 
test. To determine whether LAC affects the ability to detect asso-
ciations between genetic variations and GMR (as seen previously, 
Srivastava, Buzas et al., 2010), a median split on the LAC measure 
was applied to the entire study sample (at 839 kg), which yielded 
high and low drinking groups drinking above and below this 
median, respectively. The main analyses were repeated for these 
subgroups. For all analyses, haplotypes were constructed and 
diplotypes were estimated using PHASE version 2.0.2 (Stephens 
et al., 2001). To estimate the error rate stemming from multiple 
testing, the false discovery rate was assessed (Benjamini and 
Hochberg 1995). P < .05 was considered statistically significant.
A Manhattan plot was constructed using Haploview ver-
sion 4.2. Ingenuity Pathway Analysis identified enrichment 
in “diseases and disorders” and “molecular and cellular func-
tions” and investigated known direct or indirect molecular 
interactions between significantly associated genes (www.
ingenuity.com).
Results
Refinement of the Sample by Measured Ancestry
In the initial sample set of 103 participants, AIMs assessment 
(Enoch et al., 2006) identified 6 ethnic factors. Ten participants 
showed no clear European or African ethnicity, so they were 
excluded from further analyses. This exclusion was based on 
our previous study (Srivastava et al., 2010) that overwhelmingly 
enrolled individuals of African and European descent, and it 
also served to reduce the noise in regression modeling by reduc-
ing the number of required independent predictors. The final 
group of 93 participants was divided into low and high drinkers, 
based on the median LAC of the entire study group (Tables 1 
and 2). The Fagerstrom score was different between low drinker 
(21 smokers and 25 nonsmokers) and high drinker (33 smokers 
and 14 nonsmokers) groups (P = .002), but no significant effect 
of smoking status on GMR was observed in regression analy-
ses. The low drinking group (LAC < 839 kg) showed an average 
GMR of 0.386 ± 0.016, whereas the high drinking group had an 
average GMR of 0.372 ± 0.013, a significant difference of about 
4% (P < .001). The corresponding WM ratio was about 3% lower 
in the high vs low drinking group (P = .002), but it had no signifi-
cant effect in the whole model analyses. Within the low drinker 
group, linear regression analyses identified inverse effects of age 
(P < .001) and LAC (P = .006) on GMR.
Genetic Analyses
A total of 768 SNPs from 92 candidate genes and loci (supplemen-
tary Table 1) were genotyped for each sample in the whole data set 
from 93 individuals. Fifty-one SNPs were excluded from final anal-
yses because of low heterozygosity and 11 were excluded because 
of unreliable clustering. Therefore, 706 SNPs were used in final 
regression analyses as possible predictors of GMR. No significant 
effects of any of these SNPs on GMR in the full sample were found.
SOD2 Association Analysis
Haplotypes were constructed with SOD2 SNPs rs5746136 (tag 
SNP in present sample set) and rs4880 (Ala16Val); 9 diplotypes 
were inferred based on these haplotypes. Three of these diplo-
types were Ala16/Ala16 homozygous (H1-H3, H3-H3, and H1-H1), 
a frequency similar to that previously observed (Srivastava et al., 
2010). Mean GMR and LAC for low and high drinking groups 
across all SOD2 diplotypes are presented in Table  3. A  linear 
regression analysis in the low drinking group (GMR as depend-
ent variable; SOD2 diplotypes, age, gender, FTND, LAC, duration 
of abstinence, ancestry scores for both European and African 
ancestry as independent predictors) showed significant asso-
ciation of SOD2 diplotype with GMR (P = .009), in addition to the 
significant relationships of GMR to LAC, age, described above. 
This whole model accounted for 70% of variance of GMR in the 
low drinking group (Table 2). Tukeys posthoc analysis revealed 
that the Ala16/Ala16 -homozygous diplotype was significantly 
(P < .009) associated with the lowest GMR in the low drinking 
group but showed no significant association among the higher 
than median drinking group (Table 3).
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Global Gene-Wise Regression Analyses
Of the 67 genes, 8 showed significant associations in analyses of 
the entire sample, with GMR as dependent variable and gene-
specific independent SNPs, LAC, age, gender, smoking status, 
duration of abstinence, and African and European ancestry scores 
as independent predictors. SNPs rs2213041 from ADH1A-B-C 
cluster, rs2494731 from AKT1, rs1042389 from CYP2B6, rs534957 
from GCLC, rs2364725 from NFE2L2, rs3918188 and rs7830 from 
NOS3, rs4593985 from SLC1A2, and rs17293059 from SYT1 genes 
were associated with GMR (Table  4). Of these 8 nominally sig-
nificant associations, 4 genes were also significant predictors of 
GMR in the low drinking group (rs2213041, rs534957, rs7830, and 
rs17293059). None of the associations in the entire sample or in 
the low drinking group survived correction for multiple testing. 
The genotypes showing the lowest average GMR are presented 
in Table 4 and a graphical representation of all the uncorrected P 
values is presented in the Manhattan plot of Figure 1.
Discussion
In this large-scale hypothesis-driven genetic analysis of chronic 
alcohol-associated brain volume loss, we replicated a previous 
association between GM shrinkage and SOD2 genotype in indi-
viduals with relatively low LAC levels (Srivastava et  al., 2010). 
We also identified several novel associations between our GM 
volume measure and specific genes on a custom addiction array, 
which, however, did not survive rigorous multiple comparison 
correction. Candidate genes included in the array were those 
previously found to influence substance addiction and generally 
belonged to diverse yet biologically interconnected metabolic 
pathways. The genes are shown in supplementary Table 1 and 
can broadly be divided into 2 groups: one directly affecting the 
extent of oxidative challenge to enzymes and proteins involved 
in alcohol metabolism, ROS/RNS clearance, and antioxidant 
molecule production and another group that regulates neuronal 
function (neurotransmitter signaling and neurotrophic factor 
coding genes) and pro/antiapoptotic factors.
The most notable result of this study is the finding that the 
SOD2 diplotype (rs5746136CC-rs4880GG) containing the func-
tional missense variant (Ala16Val, rs4880) was differentially asso-
ciated with GMR in alcohol-drinking individuals, a replication of 
a previous finding in an independent cohort of alcohol-depend-
ent individuals (Srivastava et  al., 2010). The Ala16 low activity 
allele was found to be a risk factor for GM loss in individuals in 
the low drinking group (below the cohort median of 839 kg LAC) 
but not among the alcohol-dependent individuals in the high 
drinking group. This indicates that genetic protection from this 
specific gene may be ineffective at levels of alcohol consumption 
that exceed 839 kg LAC, corresponding to approximately 8 stand-
ard alcoholic drinks/d for a period of 20 years. Evidence for the 
involvement of the SOD2 genotype in chronic alcohol-associated 
GM shrinkage in 2 independent cohorts with relatively low LAC 
strongly suggests that the Ala16Val is a key genetic variant in 
alcohol-mediated brain tissue loss that conveys genetic protec-
tion only at relatively low cumulative drinking levels.
Due to the combination of African American and European 
origin subjects in this study, we evaluated the frequencies of 
the SOD2 haplotypes (rs4880- rs5746136) between African and 
European populations using a public database (HapMap v3) 
and found no significant frequency difference between them. 
In particular, the frequency of the Ala/Ala risk haplotype is 
numerically identical between these 2 diverse populations (sup-
plementary Table 2).
In addition to the critical SOD2 functional polymorphism, 
associations of other genes on the addiction array to GM volume 
in alcohol users were observed. Genetic variations from ADH, 
GCLC, NOS3, and SYT1 were significant predictors of GMR among 
individuals with lower than the median LAC, which was 839 kg 
in this cohort. These genes are in some way or another part of 
oxidative stress pathways (Figure  2). To probe the extent and 
nature of molecular interactions between these genes, we carried 
out an interaction analysis using the “connect” function in IPA. 
Different molecular interactions emerged among the candidates. 
Most of the relationships were direct (represented by solid line/
arrow in Figure 2), where 2 molecules made physical contact with 
each other such as during a phosphorylation event. The remain-
der were indirect interactions (represented by broken line/arrow), 
which did not involve physical contact between the 2 molecules, 
such as signaling events; some other genes functioned in tandem 
without molecular interactions, such as ADH and CYP2B6.
The genes encoding alcohol dehydrogenases (ADH1 A-B-
C) showed no evidence of direct or indirect interaction with 
the other genes identified to relate to alcohol-associated GM 
loss in this study. ADH1A, 1B, and 1C code for specific subunits 
and are collectively grouped into class  I ADH. Class  I ADH is 
abundant in liver and is responsible for first pass metabolism 
of alcohol (Crabb et al., 2004) directly controlling the amount 
Table 2. Effects of Independent Predictors on GMR (GMR = GM/ICV) 
in Low and High Drinking Groups
Low Drinkers High Drinkers
Variables F-ratio P value F-ratio P value
Age 32.9 <.0001 7.3 0.01
LAC (kg) 8.5 0.006 0.1 0.72
European ethnicity (AIM 
scores)
9 0.005 0.2 0.68
SOD2 diplotype 3.1 0.009 0.5 0.84
Fagerstorm score (FTND) 0.4 0.5 3.5 0.07
Full model F/R2 7.3/0.7 <.0001 1.4/0.3 0.2
 Abbreviations: AIM, Ancestry Informative Marker; FTND, Fagerstrom Test for 
nicotine dependence; GMR, gray matter ratio; LAC, Lifetime alcohol consumption.
Table 3: Mean gray matter ratio (GMR = GM/ICV) and lifetime alco-
hol consumption (LAC) for ‘low’ and high’ drinking groups across all 
SOD2 diplotypes (mean ± standard deviation)
‘Low’ drinkers ‘High’ drinkers
Diplotype GMR LAC [kg] GMR LAC [kg]
H1-H1* 0.382 ± 0.013
(n=3)
190 ± 127 0.363 ± 0.01
(n=5)
1553 ± 344.3
H1-H2 0.394 ± 0.012
(n=11)
345 ± 214.5 0.383 ± 0.009
(n=8)
1715 ± 536
H1-H3* 0.371 ± 0.013
(n=2)
72 ± 42.1 0.380 ± 0.008
(n=6)
1906 ± 1504
H2-H2 0.392 ± 0.023
(n=5)
260 ± 268 0.372 ± 0.014
(n=5)
1623 ± 470.5
H2-H3 0.383 ± 0.013
(n=12)
420 ± 239 0.373 ± 0.012
(n=17)
1592 ± 494.9
H2-H4 0.381 ± 0.002
(n=2)
448 ± 243 0.380 ± 0.006
(n=2)
1223 ± 103.3
H3-H3* 0.382 ± 0.01
(n=6)
290 ± 77 - -
H3-H4 0.373 ± 0.02
(n=3)
533 ± 107 0.374
(n=1)
2420
H4-H4 0.382 ± 0.003
(n=2)
700 ± 50 0.383 ± 0.02
(n=3)
2501 ± 155.09
+ From haplotypes constructed with SOD2 SNPs rs5746136-rs4880 (ala16val)
*Ala homozygous diplotypes
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of alcohol in systemic circulation and availability to the target 
organs. Thus, based on the efficiency of class I ADH, individu-
als with a comparable range of LAC may have varying levels of 
ROS load, which, coupled with differential efficiencies of the 
oxidative stress system, leads to largely varying degrees of GM 
tissue loss.
GCLC (Glutamate-cysteine ligase or γ-glutamylcysteine syn-
thetase) is the first rate-limiting enzyme of glutathione synthesis. 
Functional mutations in GCLC can reduce the synthesis of this 
all-important antioxidant in the brain and thereby increase oxi-
dative tissue damage. NOS3 (nitric oxide synthase 3)  or eNOS 
(endothelial NOS) is responsible for the production of NO, which 
has antioxidant properties as it, among other functions, reduces 
superoxide anion formation by inducing the expression of SOD. 
SYT1 (Synaptotagmin-1) is a member of the Synaptotagmin family 
involved in regulating neurotransmitter release. Crucial for normal 
Figure 1. Manhattan plot of all the P values obtained in the study (the P values are derived from linear regression models from each gene); red line represents uncor-
rected significant threshold P value; y-axis represents log transformed P value; X-axis represents chromosomes.
Table 4: Other genetic variations nominally predicting the gray matter ratio (GMR) in the context of alcohol exposure in the entire study 
sample (mean ± standard deviation)
Gene/Gene cluster Associated SNP R F-ratio p-value Genotype with lowest GMR
ADH1A-B-C rs2213041 *
(intergenic)
0.83 11.15 <0.0001 A A = 0.377 ± 0.010
(n=5)
AKT1 rs2494731
(intron)
0.70 3.73 0.028 C C = 0.366 ± 0.012
(n=5)
CYP2B6 rs1042389
(UTR-3’)
0.73 3.98 0.020 T T = 0.377 ± 0.017
(n=56)
GCLC rs534957 *
(intron)
0.77 6.24 0.003 G G = 0.378 ± 0.010
(n=6)
NFE2L2 rs2364725
(5’ to gene)
0.70 3.75 0.030 A A = 0.375 ± 0.016
(n=29)
NOS3 rs3918188
(intron)
0.73 4.96 0.010 C C = 0.377 ± 0.018
(n=36)
rs7830 *
(intron)
0.71 4.30 0.017 G G = 0.378 ± 0.016
(n=42)
SLC1A2 rs4593985
(intron)
0.83 4.53 0.016 C C = 0.377 ± 0.015
(n=50)
SYT1 rs17293059 *
(intron)
0.76 3.42 0.038 G G = 0.366 ± 0.019
(n=2)
* Also significant predictor of GMR in ‘low’ drinking group alone
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neuronal synaptic transmission, it has been shown recently to 
play a role in alcohol preference models (Barbier et al., 2015).
This study provides a focused and contextual analysis of 
genetic variation affecting a specialized phenotype with a small 
but functionally relevant effect size. The select polymorphisms on 
our custom array tagged maximum genetic variation per locus, 
which maximized the coverage and minimized noise. All the 
gene specific associations were adjusted for confounding effects 
of age, gender, smoking status, level of alcohol consumption, and 
ethnicity. However, none of the observed P values were significant 
following FDR correction. The effect sizes of genes on an inter-
mediate phenotype are expected to be larger than observed in 
our study (Hodgkinson et al., 2010). A retrospective power calcu-
lation assuming an average of 5 independent SNPs per gene per 
regression model estimated a sample size of 847 and 122 individu-
als to achieve a statistical power of 80% for small and medium 
effect sizes, respectively. Our sample size was marginally short of 
medium effect size. Thus, in all probability this is the reason why 
the phenotype of alcohol-induced GM loss shows a small effect 
size. Collecting a large sample number for such phenotypes is a 
limitation at clinical and practical levels that can be overcome by 
pooling and harmonizing data from different studies/laboratories. 
Nonetheless, and considering that genetic association signals 
have been rarely replicated, replication of a previously reported 
association of SOD2 Ala16Val polymorphism with GMR in an 
independent sample is the highlight of this study. Furthermore, 
we provide the first cataloging of genetic variations relevant to 
GM tissue loss associated with chronic alcohol consumption. It 
is important to note that no significant genetic associations were 
observed in patients who chronically consumed large amounts of 
alcohol (>8 standard alcoholic drinks/d or a mean of 16 alcoholic 
drinks/d for 20  years), signifying that genetic protection from 
a specific SOD2 SNP is ineffective at very high levels of alcohol 
intake. Nevertheless, the reported associations in the low drinking 
group are informative, functionally pertinent, and merit follow-up.
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